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Background: In the past, numerous methods have been developed for predicting antigenic regions or B-cell
epitopes that can induce B-cell response. To the best of authors’ knowledge, no method has been developed for
predicting B-cell epitopes that can induce a specific class of antibody (e.g., IgA, IgG) except allergenic epitopes (IgE).
In this study, an attempt has been made to understand the relation between primary sequence of epitopes and
the class of antibodies generated.
Results: The dataset used in this study has been derived from Immune Epitope Database and consists of
14725 B-cell epitopes that include 11981 IgG, 2341 IgE, 403 IgA specific epitopes and 22835 non-B-cell
epitopes. In order to understand the preference of residues or motifs in these epitopes, we computed and
compared amino acid and dipeptide composition of IgG, IgE, IgA inducing epitopes and non-B-cell epitopes.
Differences in composition profiles of different classes of epitopes were observed, and few residues were
found to be preferred. Based on these observations, we developed models for predicting antibody
class-specific B-cell epitopes using various features like amino acid composition, dipeptide composition, and
binary profiles. Among these, dipeptide composition-based support vector machine model achieved
maximum Matthews correlation coefficient of 0.44, 0.70 and 0.45 for IgG, IgE and IgA specific epitopes
respectively. All models were developed on experimentally validated non-redundant dataset and evaluated
using five-fold cross validation. In addition, the performance of dipeptide-based model was also evaluated
on independent dataset.
Conclusion: Present study utilizes the amino acid sequence information for predicting the tendencies of
antigens to induce different classes of antibodies. For the first time, in silico models have been developed for
predicting B-cell epitopes, which can induce specific class of antibodies. A web service called IgPred has been
developed to serve the scientific community. This server will be useful for researchers working in the field of
subunit/epitope/peptide-based vaccines and immunotherapy (http://crdd.osdd.net/raghava/igpred/).
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Innate and adaptive immune responses are the two main
arms of host immune system to combat invading patho-
gens. The innate immunity, also known as first line
defense, is non-specific and responsible for the immedi-
ate action against infection. On the other hand, adaptive
immunity is a highly specialized type of defense system,
where the immune system first recognizes pathogen and
then develops pathogen-specific defense mechanisms. In
addition, adaptive immunity also generates memory cells
that can handle pathogen effectively and rapidly if the
system is attacked later by the same pathogen. The
adaptive arm of immunity can be divided broadly into
two categories; humoral and cell-mediated, responsible
for activating B-cells and T-cells respectively.
Vaccination is an artificial procedure for sensitizing
immune response or generating memory cells against a
desired pathogen. Over the years, subunit vaccine design
has become an integral part of vaccine design in which
immunogenic region of protein is used instead of
complete pathogen or antigen [1]. Antibodies (Abs) are
one of the important components of humoral immunity
where B-cells recognize antigenic regions or B-cell epi-
topes (BCEs) and generate antigen specific Abs. These
Abs perform various functions such as phagocytosis [2],
cell-mediated cytotoxicity [3], neutralization, compli-
ment activation [4] and mast cell binding [5]. Broadly
these Abs can be categorized in five classes or isolates
i.e., IgA, IgD, IgE, IgG, and IgM.
It has been observed in the past that particular patho-
gen/antigen induce defined class or subclass of Abs, for
example, infections like schistosomiasis and filariasis
induce a mixed response of IgE and IgG [6-8]. In case of
protozoan like Plasmodium falciparum, Ab response of
merozoite surface proteins constitutes mainly IgG1 and
IgG3 subclasses [9,10]. On the other hand, viruses like
rotavirus, HIV and influenza virus, are well known for
inducing IgA type of response [11]. In case of IgE indu-
cing antigens (allergens), the studies showed that the
allergens have some features that make them allergenic
[12]. These facts together suggest that there are desired
effector functions of Abs, which are needed to encounter
various types of pathogens. Thus, it is important to
understand why the immune system produces different
classes of antibodies against different antigens. This un-
derstanding will help an experimental biologist to design
a better vaccine for the induction of systemic or mucosal
immunity as well as immunotherapy. In the past, numer-
ous databases and methods have been developed for
maintaining and predicting BCEs in an antigen [13-16].
Till date, limited efforts have been made to develop the
method for predicting allergens or BCEs that can induce
IgE type of antibodies [17,18]. To the best of authors’
knowledge, no comprehensive attempts have been madefor predicting BCEs responsible for inducing specific
class of Abs or discrimination of epitopes that induce
different class of Abs.
In this paper, we have made an attempt to understand
the relation between amino acid sequence of epitopes
and type of Abs they will induce. First we have collected
IgG, IgE and IgA specific BCEs from Immune Epitope
Database (IEDB). Subsequently, these three classes of
epitopes were analyzed to understand which residues or
group of residues are preferred among these sequences.
Based on comparative analysis, we developed prediction
models using various features like amino acid compos-
ition, dipeptide composition and binary profiles. We also
developed a user-friendly platform for the scientific





In order to ascertain whether certain types of residues
are dominated in different classes of BCEs, the percent
average amino acid composition of IgG, IgE and IgA
specific BCEs and non-B-cell epitopes (non-BCEs) was
calculated and compared (Figure 1). The analysis revea-
led that there are differences in the percent average
amino acid composition profiles of four classes (IgG,
IgE, IgA, and non-BCEs) of epitopes. As shown in
Figure 1, certain types of residues are abundant in each
class, for instance Pro and Gln are abundant in IgA
inducing epitopes while Cys and Glu are found to be
dominated in IgE inducing epitopes. These observations
are in accordance to several previous reports, where
researchers have shown that there is a propensity of Cys
residues in IgE inducing epitopes, and they form stable
conformational epitopes through disulphide bonds [19-25].
It has also been observed in the past that IgA binding
antigenic regions are Pro/Gly rich [26,27].
Dipeptide composition provides more information
than amino acid composition and has been used in the
past for developing various classification models [28-30].
We have also computed and compared average dipeptide
composition for each class of epitopes (IgG, IgE, IgA
and non-BCE). It was observed that each class of epi-
topes has certain types of dipeptides having significantly
higher composition (Welch’s t-test) than other class of
epitopes. Dipeptides AS, GP, WK, YR, etc. are prevailing
in IgG; IQ LA, NA, NE, etc. are frequent in IgE, and ED,
FP, PF, PQ, PY, QP, etc. are predominant in IgA class of
epitopes (Additional file 1).
Residue preference
In order to understand the preference of residues at
different positions in epitopes, we analyzed two sample
Figure 1 Comparison of average amino acid composition of different class of epitopes.
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certain residues are preferred at specific positions in
each class. For example, in IgG inducing epitopes, Pro,
Gly and Met are preferred at the first position and Pro
and Arg are preferred at second position. Overall, Pro is
found to be preferred at almost every position. In IgE
inducing epitopes, Gln, Glu and Cys are found to be
preferred at various positions. In IgA inducing epitopes,
an exclusive preference of Gln and Pro is observed
(Figure 2).
Length of epitopes
In order to understand whether the length of epitopes
plays any role in inducing specific class of antibodies, weFigure 2 Two sample logos for each class of epitopes where epitopes
negative examples.examined the length of different class of epitopes. As
shown in Figure 3, most of the epitopes are between 4
and 20 residues in length, only few epitopes having
length more than 40 residues. Analysis revealed that
more than 55% IgA specific epitopes are less than 10
residues in length while more than 45% IgE specific
epitopes are between 11 and 15 residues in length. IgA
inducing epitopes have length between 4–10 residues.
Physico-chemical property analysis
We computed and compared the physico-chemical prop-
erties of various epitopes to understand their correlation
with antibody-class specificity. We did not find any signifi-
cant differences in physico-chemical properties betweenof a class is taken positive and the rest of peptides as
Figure 3 Lengthwise distributions of class-specific epitopes.
Table 1 The performance of SVM models developed for




IgG epitope IgE epitope IgA epitope
ACC MCC AUC ACC MCC AUC ACC MCC AUC
AAC 63.85 0.28 0.68 75.33 0.51 0.81 71.46 0.43 0.76
AAP 68.30 0.37 0.73 78.3 0.57 0.85 72.93 0.46 0.78
CTD 64.30 0.29 0.69 68.81 0.38 0.71 69.76 0.40 0.74
DPC 70.42 0.41 0.76 82.7 0.66 0.88 72.07 0.44 0.78
PCP 66.18 0.32 0.71 64.31 0.29 0.64 72.8 0.46 0.78
(ACC accuracy, MCC Matthew’s correlation coefficient, AUC area under curve).
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polar, aliphatic and positively charged residues, which
showed differences in their composition both in IgA and
IgE classes. In the past, few attempts have been made to
differentiate BCEs from non-BCEs based on physico-
chemical properties and shown similar observations [32].
Motifs analysis
Since motif-based distinction of IgA epitopes has been
reported in the past [11], we extracted motifs from other
classes (IgG and IgE) considering the fact that few motifs
might be present in these classes, as well. We performed
MEME (see Method section) studies for the discovery of
motifs in all classes and extracted 20 motifs at default
parameters of MEME (Additional file 3: Table S1). We
have implemented this motif information at our server
where user can scan their epitopes for the presence of
specific motifs.
Models for predicting antibody-specific BCEs
In this study, we have developed numerous models for
predicting IgG, IgE, and IgA specific BCEs. We built
models for each class on all the datasets. The perform-
ance of models was optimized, for example, in case of
SVM; parameters were tuned for all three types of
kernels linear, polynomial and radial bias.
SVMlight models developed on BalanceVar dataset
(i) Composition-based model. Since significant
differences were observed in amino acid and
dipeptide composition of each class of epitopes,
first we have developed SVM models using amino
acid composition as input feature and achievedmaximum MCC values 0.28, 0.51 and 0.43 for IgG,
IgE and IgA respectively. The performances of
amino acid composition-based models are
summarized in Table 1 and Additional file 3:
Table S2. Next, SVM models were developed based
on dipeptide composition of epitopes. Dipeptide-
based models performed better than the amino acid
composition-based model and achieved maximum
MCC of 0.41, 0.66 and 0.44 for IgG, IgE and IgA
respectively (Table 1 and Additional file 3: Table
S2). Detailed performances of dipeptide-based
model at different thresholds are summarized in
supporting information (Additional file 3: Table S3).
(ii) Physico-chemical properties-based model. We
developed models based on physico-chemical
properties (PCP) using 10 physico-chemical
properties of BCEs and non-BCEs. These models
were further optimized in order to improve the
performance. We achieved maximum MCC of 0.32,
0.29 and 0.46 for IgG, IgE and IgA respectively
(Table 1 and Additional file 3: Table S2). Further,
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composition-transition and distribution (CTD) as
input, which has been used in the past for predict-
ing BCEs [33] and achieved MCC of 0.29, 0.38 and
0.40 for IgG, IgE and IgA respectively (Table 1 and
Additional file 3: Table S2). The performance of
both PCP and CTD-based models on threshold
dependent, as well as on threshold independent
parameters were poorer than dipeptide-based
models. In addition, we developed models using
amino acid pairs propensity (AAP) and achieved the
performance more or less similar to dipeptide-based
model. AAP based model achieved maximum MCC
of 0.37, 0.57 and 0.46 for IgG, IgE and IgA respect-
ively (Table 1 and Additional file 3: Table S2).
SVMlight models developed on BalanceFix dataset
(i) Composition-based model. We built models on
BalanceFix dataset using amino acid composition as
input feature and achieved MCC of 0.33, 0.64 and
0.39 for IgG, IgE and IgA respectively (Table 2 and
Additional file 3: Table S4). Similarly, SVM models
developed with dipeptide composition profile
achieved MCC of 0.44, 0.70 and 0.45 for IgG, IgE
and IgA respectively. The AUC values for the
models were 0.77, 0.9 and 0.78 for IgG, IgE and
IgA respectively. Detailed performances of
dipeptide-based model at different thresholds are
summarized in supporting information
(Additional file 3: Table S5).
(ii) Physico-chemical properties-based model.
Further, SVM models were developed using PCP
which achieved MCC of 0.13, 0.16 and 0.27 for IgG,
IgE and IgA respectively. The maximum
performance of CTD model on this data in term of
MCC was 0.15, 0.28 and 0.27 for IgG, IgE and IgA
respectively (Table 2 and Additional file 3: Table S4).
Furthermore, models on BalanceFix dataset usingTable 2 The performance of SVM models developed for




IgG epitope IgE epitope IgA epitope
ACC MCC AUC ACC MCC AUC ACC MCC AUC
AAC 66.27 0.33 0.70 81.78 0.64 0.86 69.29 0.39 0.75
AAP 69.29 0.39 0.75 82.39 0.65 0.89 74.34 0.49 0.79
CTD 57.41 0.15 0.61 63.99 0.28 0.70 63.3 0.27 0.67
DPC 71.73 0.44 0.77 84.96 0.70 0.90 72.28 0.45 0.78
PCP 56.57 0.13 0.59 58.11 0.16 0.62 63.3 0.27 0.69
BIN 54.02 0.08 0.55 56.17 0.12 0.59 62.17 0.24 0.67
(ACC accuracy, MCC Matthew’s correlation coefficient, AUC Area under curve).AAP achieved maximum MCC of 0.39, 0.65 and 0.49
for IgG, IgE and IgA respectively.
(iii) Binary profile-based model. Since BalanceFix
dataset consists of fixed length epitopes, therefore,
we developed model using binary profile of epitopes
as input features to predict antibody-specific BCEs.
The binary based models achieved maximum MCC
of 0.08, 0.12, 0.24 for IgG, IgE and IgA respectively
(Table 2 and Additional file 3: Table S4).
In addition, we also developed SVM models for each
class on realistic datasets i.e. RealVar and RealFix data-
sets. The dipeptide-based SVM models performed best
among the rest of the models. The performance of
models developed on realistic datasets is summarized in
supporting information (Additional file 3: Table S6 and
Additional file 3: TableS7).
Models developed using WEKA
We developed models based on BayesNet, Complement
NaiveBayes, NaiveBayes, NaiveBayes Multinomial, SMO,
IBk (kNN), J48, and RandomForest using WEKA for
predicting antibody-specific BCEs. After tuning different
parameters, we found that out of many algorithms of
WEKA, three algorithms SMO, kNN and Random
Forest performed comparatively better as shown in
supporting information (Additional file 3: Table S8 and
Additional file 3: TableS9). Balanced set of patterns for
both variable (BalanceVar) and fixed (BalanceFix) length
were used for all three classes and evaluated using five-
fold cross validation technique as shown in the supple-
mentary information (Additional file 3: Table S8 and
Additional file 3: Table S9).
The best classifiers of WEKA achieved maximum accur-
acy 70.07% for IgG [KNN: 0, window size: 0, algorithm:
LinearNN search], 81.50% for IgE [SMO, polykernel -C
250007 -O 1.0, c: 1.0, epsilon: 1.0E-12] and 71.16% for IgA
[Randomforest, numFeature: 15, numTrees: 10, Seed: 1].
These results were comparable to SVM models imple-
mented using SVMlight, where it achieved maximum
accuracy of 70.42%, 82.70% and 72.07% for IgG, IgE and
IgA respectively.
Performance of model on independent dataset
In order to evaluate the performance of our models on
independent data, we first trained our models on 80% of
data by ten-fold cross validation and later the perform-
ance of the best models were evaluated on remaining
20% independent data. We evaluated dipeptide based
model on all the datasets for all classes of epitopes. The
performances of these models are summarized in Table 3.
On BalanceVar data, model (ten-fold cross validation)
developed on training data achieved maximum MCC of
0.42, 0.61 and 0.39 while MCC of 0.37, 0.63 and 0.49
Table 3 The performance of dipeptide composition based
SVM models, evaluated using ten-fold cross validation on
training data (80%) and independent validation on
independent data (20%) on BalanceEval (BalanceFix &
BalanceVar) dataset
Dataset Mode Data size ACC MCC AUC
BalanceVar IgG Training 6063 70.88 0.42 0.76
Evaluation 1519 68.24 0.37 0.74
IgE Training 1873 80.53 0.61 0.87
Evaluation 468 81.49 0.63 0.88
IgA Training 322 69.60 0.39 0.75
Evaluation 80 74.69 0.49 0.79
BalanceFix IgG Training 4893 70.87 0.42 0.76
Evaluation 1223 71.67 0.43 0.78
IgE Training 1524 85.04 0.70 0.90
Evaluation 381 80.97 0.62 0.86
IgA Training 213 73 0.46 0.80
Evaluation 54 66.67 0.33 0.72
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IgA classes respectively. Similarly, for BalanceFix data,
model performed reasonably well and achieved max-
imum maximum MCC of 0.42, 0.70 and 0.46 on training
data while MCC of 0.43, 0.62 and 0.33 were achieved on
evaluation datasets of IgG, IgE and IgA classes respect-
ively. The performance of every ten fold cross validation
model on the evaluation set was comparable to that of
five fold cross validation model made on main data.
Taken all these results together, it can be speculated that
our model performed consistently well, and high accur-
acy is not due to over optimization.
Implementation and utility of IgPred
We have developed a user-friendly web server ‘IgPred’
(Figure 4) for predicting antibody-specific BCEs. A num-
ber of useful tools have been integrated to IgPred, and
their descriptions is as follows:
(i) Epitopes in peptides: This tool allows users to
predict antibody-specific epitopes in their peptide
sequences. User can select either variable length, or
fixed length peptides option provided at server. In
case of variable length peptides, the models were
built on variable length data. Here, server allows
users to submit multiple peptides in FASTA format
for predicting epitopes. In case of fixed length
peptides, the models were developed on fixed
length data, so on server users may submit multiple
peptides of fixed length in FASTA or plain format
for predicting epitopes.
(ii) Epitopes in proteins: This tool allows users
to identify antigenic regions (BCEs) in proteinsequences, which can induce particular class
of Ab. There are two options for users as
described above. First option is mapping with
variable length, and other is mapping with
fixed length window.
(iii) Mapping with experimental data: This tool
allows users to map experimentally verified
class-specific BCEs on user’s antigen sequence.
(iv)MotifScan: This module is designed to scan Ab
class-specific motifs in an antigen sequence
provided by the users. These motifs were
derived from experimentally validated BCEs
that induce IgG, IgE and IgA Abs using
MEME/MAST software as mentioned
in method.
(v) Similarity search: This option allows users to
search known (experimentally validated) BCEs in
their antigen sequence using Smith-Waterman
similarity search algorithm.
In the prediction tools, users can select an SVM
threshold for the class of antibody that is going to be
generated. We suggest that if high confidence in predic-
tion is needed, user should select high threshold value,
but at the same time sensitivity of the prediction will be
compromised. The results can be downloaded immedi-
ately or can be delivered by email. The common gateway
interface (CGI) script for IgPred was written using PERL
5.03. IgPred is freely available at http://crdd.osdd.net/
raghava/igpred/.
Discussion
In the past, several methods have been developed for
predicting BCEs in an antigen/protein sequence from
their primary structure [15,34-37]. To the best of au-
thors’ knowledge no comprehensive method has been
developed so far for predicting class–specific BCEs, ex-
cept few methods developed for IgE inducing allergenic
epitopes [17,38,39]. The present study is an attempt in
the direction to understand differences between the
BCEs that induce different classes of antibodies like IgG,
IgE and IgA. We hypothesized that induction of different
classes of antibodies (i.e. IgG, IgE and IgA) could be
determined by the sequence of an epitope. Therefore, to
understand this, we first extracted BCEs that induce
IgG, IgE and IgA types of antibodies from the IEDB
database, and then these sequences were systematically
analyzed. Amino acid and dipeptide composition ana-
lysis revealed that the composition of certain residues/
dipeptides is higher in certain antibody-specific epitopes
than the others. In addition, few residues are preferred
in a particular class suggesting that these residues or
dipeptides may play an important role in class switching.
For example, Pro and Gln are significantly dominant in
Figure 4 Schematic representation of IgPred webserver.
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residue in any of the regular secondary structures, this
residue might be contributing in induction of IgA. Based
on these observations, it is clear that the composition of
sequence (residue or dipeptide) can be used to discrim-
inate epitopes of different class. Therefore, we developed
models using amino acid and dipeptide composition as
input features. As shown in results section, models
based on dipeptide were able to classify the epitope of
different classes with reasonably high accuracy. All
models were evaluated using both threshold dependent
and independent parameters. In addition to SVM models,
we also developed models using various modules of
WEKA package. It was observed that models based on
classifier SMO, kNN and Random Forest perform better
than other classifiers of WEKA. It was also observed that
overall SVM-based models implemented using SVMlight
performed better than models developed using WEKA as
explained in results section.
We further developed SVM model using binary pro-
files of patterns as input features. In addition, we also
developed models using various other features like PCP,
CTD and AAP, but none of the methods achieved accur-
acy higher than dipeptide-based models. The perform-
ance of dipeptide-based model were also evaluated by
ten-fold cross validation and performance was almost
similar to five-fold. We evaluated the performance of
ten-fold cross validation models on independent data-
sets and achieved reasonable accuracy (as mentioned
in the result section). Our results suggest that per-
formance of our models is not due to the overoptimization; thus our method will be useful and
effective in real life.
In our study, we used one vs. rest approach for creat-
ing datasets. It means for developing models for predict-
ing IgA epitopes; we used IgA epitopes as positive set
and the rest of the epitopes (IgE, IgG and non-BCE) as
negative set. However, we have not used one vs rest
approach for prediction, it means our predictions are
not exclusive prediction for a single class and our
models may predict a peptide inducing for more than
one class of antibodies based on prediction score. In
a situation where a peptide has equal score for two
models then it can be assigned to both the classes if
the score for both classes is more than the threshold.
The dimensions provided in IgPred webserver enable
users to determine the potency of any antigen to in-
duce systemic, allergic or mucosal Ab immune res-
ponse beforehand.
Conclusion
In the present study, we have made an attempt to
establish a relation between an antigenic amino acid
sequence and its tendencies to generate systemic
(IgG), allergic (IgE) and mucosal (IgA) type of Ab
response. For the first time, in silico models have
been developed for predicting class-specific BCEs. We
have implemented our methods in the form of a web
server -IgPred. We anticipate that IgPred will be
beneficial in designing a better vaccine and immuno-
therapy, with most appropriate effector function, and
several other clinical applications.
Gupta et al. Biology Direct 2013, 8:27 Page 8 of 15
http://www.biologydirect.com/content/8/1/27Methods
Dataset creation
In this study, datasets were derived from B-cell assays of
human and mouse, which were extracted from Immune
Epitope Database (IEDB) (http://www.iedb.org/). Of these
sequences, B-cell assay positive epitopes were considered
as BCEs (positive examples) and B-cell negative epitopes
were considered as non-BCEs (negative examples). Since
these sequences are of variable length (from 4–100 amino
acids), only non- redundant (unique) sequences having
a length between 4 to 50 amino acids were taken. These
epitopes were divided into three classes on the basis of
antibody heavy chain (IgG, IgE and IgA) reported in the
IEDB database. Finally, we obtained 11981, 2341, 403
and 22835 sequences for IgG, IgE, IgA specific BCEs
and non-BCEs respectively. Non-BCEs are entirely dif-
ferent from the IgG, IgE and IgA specific BCEs and
nowhere present in positives. Therefore, we treated it as
a separate class. From the above data, we have derived
following datasets for developing various models. The
approach for developing datasets (BCEs and non-BCEs)
and selecting features has been adopted from the previ-
ous study by our group [35]. In this study, authors
developed a method, which efficiently classify BCEs from
non-BCEs. Here, in the present study, we wanted to take
it to the next step to classify BCEs into class-specific
BCEs. The overview of dataset creation is summarized
in Figure 5.
(i) Realistic dataset with variable length
(RealVar dataset): This dataset consists of total
14725 BCEs (i.e., 11981 IgG-specific, 2341
IgE-specific, 403 IgA-specific BCEs) and 22835
non-BCEs of variable lengths (Table 4)
(ii) Balanced dataset with variable length
(BalanceVar dataset): This dataset was created
from the above mentioned RealVar dataset. In this
dataset, positive examples were balanced by taking
equal number of negative examples from totalFigure 5 Overview of dataset creation.negatives. First, to avoid biases, 4942 negative
examples were picked randomly from non-BCEs
(22835), which is equivalent to one third of all
BCEs (IgG, IgE, and IgA). Subsequently, balanced
dataset of each class was developed taking equal
number of negative examples randomly from total
negatives (Table 4). Since machine learning tech-
nique need fixed length pattern and also it is diffi-
cult to predict epitopes in an antigen using model
trained on variable length datasets as length is not
fixed for scanning, we have developed two other
datasets of fixed length. These datasets are derived
from the above two datasets.
(iii) Realistic dataset with fixed length
(RealFix dataset): In order to utilize the full
potential of machine learning techniques, we fixed
the length to 20 residues as most epitopes have
length up to 20 residues. This has been
implemented using extension truncation
technique as described previously [40,41]. After
removing redundant epitopes, we got 9660, 1905,
267 and 20589 for IgG, IgE, IgA and non-BCEs
respectively (Table 4).
(iv) Balanced dataset with fixed length epitopes
(BalanceFix dataset): This dataset was generated
from RealFix dataset using the same process as
described above for creating BalanceVar dataset. It
consists of 9660, 1905, and 267 BCEs for IgG, IgE,
and IgA respectively and an equal number of
negative examples for the respective class as
summarized in Table 4.
(v) Independent dataset: In order to create an
independent dataset, 20% sequences were randomly
picked from BalanceFix (for fixed length) and
BalanceVar (for variable length) dataset and used as
independent dataset. Model was trained on rest 80%
sequences using ten-fold cross validation and then
performance of the optimized model was validated
on independent dataset.
Table 4 Various datasets used for developing prediction models in the present study
Dataset type IgG IgE IgA
Positive Negative Positive Negative Positive Negative
RealVar 11981 25579 2341 35219 403 37157
BalanceVar 7598 7598 2341 2341 403 403
RealFix 9660 22761 1905 30516 267 32154
BalanceFix 6116 6116 1905 1905 267 267
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We developed models for predicting epitopes inducing
different Abs. In order to develop model for epitopes
inducing a specific class of Ab (e.g. IgA inducing
epitopes), we used IgA inducing epitopes as positive ex-
amples, and the rest of the epitopes belong to other clas-
ses (e.g., IgE, IgG and non-BCE) as negative examples
(Additional file 2: Figure S2). Similarly, for developing
model for IgG inducing BCEs, IgG-specific BCEs were
considered as positive examples and the rest of the epi-
topes from other classes (IgE specific, IgA specific BCEs
and non-BCEs) were considered as negative examples
(Additional file 2: Figure S2).
Amino acid composition
Amino acid composition is one of the simplest features,
which have been used in the past to encapsulate the
global information of protein into a fixed length pattern
[42,43]. Amino acid composition of a peptide is propor-
tional to frequency of each type of residue in a peptide.
As there are 20 types of residues, so there are 20 types
of composition for each peptide. Thus, a vector of 20 is
used to represent an epitope as described in previous
studies [44].
Dipeptide composition
Dipeptide composition is another important feature,
which is used to transform the variable length of pep-
tides to fixed length feature vectors. Dipeptide composi-
tions have been used in earlier studies to classify various
classes of peptides [44,45]. Dipeptide composition pro-
vides information of the pair of residues in contrast to a
single residue and provides a fixed pattern length of 400.
We computed percent of occurrence of each type of
dipeptide and used this information for developing
machine learning models. Following formula has been
used for computing dipeptide composition of each
epitope
Percentage of Dip ið Þ ¼ Totalnumber of Dip ið Þ
Total number of all possibleDips
 100
ð1Þ
where Dip(i) is a dipeptide i out of 400 dipeptides.To analyse the differences between dipeptide com-
position among all classes of epitopes (IgG-, IgE-, IgA-
inducing and Non-BCE), we performed significance test
(Welch’s t-test). For example, we first calculated average
of dipeptide compositions (400 dipeptides) for both
IgG(+) data and IgG(−) data. Next, we calculated the
difference of means in both the datasets for each of
the 400 dipeptides for IgG-, IgE-, IgA-inducing BCEs and
non-BCEs respectively. We also computed whether the
difference in the mean of dipeptide composition is sig-
nificant or not using t-test. Several dipeptides show a sig-
nificant difference in composition between positive and
negative dataset of each class (Additional file 1).
Binary profile of patterns
We used binary profiles of patterns for fixed length data-
sets where each amino acid was presented by a vector of
dimension 20 as described previously [44]. Since the
length of epitopes was 20, a pattern of window length 20
was represented by a vector of dimension (20 × 20). In
the past, binary profile has been used for developing pre-
diction models [44-47].
Physico-chemical properties
It is well known that function of a peptide is governed by
its primary sequence and their physico-chemical pro-
perties. Therefore, in the present study, we have selected
ten commonly used physico-chemical properties. These
properties include hydrophobicity, bulky side chain, net-
hydrogen, stearic hindrance, amphipathicity, hydrophilicity,
charge, pI value, etc. [48,49].
MEME/MAST
MEME/MAST module has been used previously for
discovering novel motifs in various classes of proteins
and peptides [44]. We have adopted the similar strategy
in the present study for discovering various motifs in
epitopes using MEME/MAST module. This module
comprises of two programs: one is MEME, which is used
to discover motifs, and other is MAST, used for search-
ing motifs [50,51]. In the present study, we have used
MEME for discovering motifs in IgG, IgE and IgA indu-
cing epitopes and subsequently, these discovered motifs
were used further for identifying epitopes using MAST.
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CTD has been used in several machine learning algo-
rithms [33] to get a fixed length vector from variable
length data. Each peptide sequence was mapped into a
string defined by three symbols. These symbols were
resulted from grouping of all amino acids into three
groups, on the basis of certain physico-chemical proper-
ties. For every physico-chemical property, we got a string
of 1, 2 and 3 symbols; three feature given by compos-
ition, three feature given by the percent frequency of i
followed by j or j followed by i (transition) and five
features per symbol. Thus total 15 features representing
the fractions of the entire sequence where the first, 25,
50, 75, and 100% of the candidate symbol are contained
in string (distribution).
Amino acid pairs propensity scale
It has been reported that some amino acid pairs found
more frequently in BCEs than in non-BCEs. Keeping this
in mind, we developed an AAP propensity scale as
reported previously [33,34]. The frequencies were calcu-
lated from positive and negative data sequences [52].
AAP features can be viewed as dipeptide composition
features weighted by the amino acid propensity of each
dipeptide. The final vector size in AAP is 400 .
Software for extraction of features and implementing
machine-learning techniques
The calculations for different features have been carried
out using in-house PERL scripts and R package (2.10.1)
scripts. Plots were made using SigmaPlot 10.0. We used
SVM_Light software (http://svmlight.joachims.org/) for de-
veloping SVM based models. SVM is freely available for
academic use and has been used in number of research
papers [29,53,54]. We also used WEKA 3.2 package
(http://www.cs.waikato.ac.nz/ml/WEKA/) to develop vari-
ous types of models. We used nine algorithms of WEKA
package namely BayesNet, Complement NaiveBayes,
NaiveBayes, NaiveBayes Multinomial, SMO, IBk, J48,
and RandomForest [55].
Evaluating the performance of models
In the present study, we used five-fold cross validation
technique to evaluate the performance of our models
developed for predicting antibody-specific epitopes. In
this technique, one fifth of total data is used for testing
and remaining data is used for training the model and
this process is repeated till all instances are evaluated.
Similarly, we also run ten-fold cross validation, which
was preceded by evaluation on independent dataset to
validate the performance of the model. In addition, in
order to evaluate the performance of models, we
included both threshold dependent and threshold inde-
pendent parameters. In case of threshold dependentparameters, we used standard parameters like sensitivity
(Sen), specificity (Spe), Overall accuracy (Acc) and
Matthews’s correlation coefficient (MCC) using following
equations.
Sens ¼ TP
TP þ FN  100 ð2Þ
Spec ¼ TN
TN þ FP  100 ð3Þ
Acc ¼ TP þ TN
TP þ FP þ TN þ FN  100 ð4Þ
MCC ¼ TPð Þ TNð Þ− FPð Þ FNð Þﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
TP þ FP½  TP þ FN½ p TN þ FP½  TN þ FN½ 
ð5Þ
[TP = true positive; FN = false negative; TN = true nega-
tive; FP = false positive; Sens = Sensitivity; Spec = Specificity;
Acc =Accuracy]
To evaluate the performance of models using thresh-
old independent parameters, AUC (Area under curve
curve) have been calculated with the help of PERF
software.
Response and revision of the manuscript in light of
the reviewer comments:
Reviewers’ comments on the original manuscript
We are grateful to the reviewers’ for their useful thoughts
and suggestions. We have incorporated all the suggestions
of the reviewers in our manuscript. Here, we are address-
ing all comments of reviewer’s point-by-point.
Reviewer number 1: Dr. M Michael Gromiha
In this work, authors have developed a method for
predicting different types of B-cell epitopes. They have uti-
lized several features such as amino acid and dipeptide
compositions, physicochemical properties and binary pro-
files. The method showed a correlation coefficient in the
range of 0.44 to 0.70 to various types of epitopes. Further,
a web server has been developed for application purposes.
Reviewer comments: The composition analysis shows
the preference of Pro in IgA. Pro is usually not a pre-
ferred residue in any of the regular secondary structures.
The higher occurrence of Pro may be discussed. Further,
the abundance of Cys in IgE may be commented.
Authors’ response: It has been shown in previous
studies [56,57] that most of residues in BCEs fall in non-
regular (coil or tight-turns) secondary structure. In re-
vised paper, we have discussed the preference of Pro and
Cys in IgA- and IgE-inducing epitopes respectively.
Reviewer comments: The residue pair preference
showed the dominance of Pro with other residues only
in IgG and IgA and not in IgE. This may be discussed.
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of residues preferred in the different classes of BCEs
have been calculated. We have no idea (biological signifi-
cance of observation) why Pro with other residues (pair)
is more abundant in IgG- and IgA- inducing epitopes
and not in IgE-inducing epitopes. This is an interesting
point to be studied in the future for understanding the
above observation.
Reviewer comments: It has been shown that IgE can
be predicted with higher accuracy than other epitopes.
The reason may be explained.
Authors’ response: It has been observed that IgE-
inducing epitopes are more conserved in comparison to
other classes of epitopes, which could be responsible for
higher accuracy.
Reviewer comments: The expansions for the parame-
ters used in SMO may be given.
Authors’ response: As suggested by the reviewer, in
revised version of the manuscript, we have described
SMO parameters in detail.
Reviewer comments: It is necessary to give the pro-
cedure used to remove the redundancy.
Authors’ response: In revised manuscript, the proced-
ure to remove the redundant or duplicate peptides has
been described.
Reviewer comments: Quality of written English:
Acceptable
Reviewer number 2: Dr Christopher Langmead
(nominated by Dr Robert Murphy)
The manuscript presents an SVM-based method for
predicting antibody-specific epitopes. Three classes were
considered: IgA, IgE, IgG. Features included AA com-
position, dipeptide composition, and physio-chemical
properties. Training data were obtained from the IEDB,
and machine-learning methods were performed using
either SVMLight or WEKA. A website for performing a
variety of tasks associated with epitope prediction is also
reported.
The study has some flaws that need to be addressed.
Reviewer comments: The results obtained with
SVMLight are the result of tuning parameters, whereas
the results obtained for the strawman models are the
result of using WEKA’s default parameters. To be fair,
the authors must do parameter searches for these.
Authors’ response: We agree with the reviewer, in our
revised manuscript, we have reported the performances of
strawman models after parameter optimization (see
Additional file 3: Table S1).
Reviewer comments: Did the authors try a string
kernel for the SVMLight experiments? It would seem
appropriate, given the nature of the data.
Authors’ Response: In the present study, we have
tried only three kernels of SVMLight namely Linear,Polynomial and Radial basis. It is possible that string
kernel may perform better than above kernels, but
unfortunately, our group does not have expertise in
optimization of string kernel parameters. In addition,
previous studies have indicated that radial basis is an
efficient kernel for discriminating various types of
peptide/epitopes.
Reviewer comments: The authors need to explain
what they do in the event of a tie in their one-vs-rest
approach to multi-class classification.
Authors’ response: In this study, we used one verses
rest approach for creating datasets only, and not for pre-
dicting epitopes, for example, to develop prediction
model for IgA-inducing epitopes, we created a dataset
containing IgA-inducing epitopes as positive examples
and remaining epitopes (IgE-, IgG-inducing epitopes and
non-BCEs) as negative examples. We computed perfor-
mance of models based on the threshold, for example, in
IgA model if a peptide having SVM score above the
threshold then it is assigned as IgA-inducing epitope.
We have not used exclusive prediction for a single class
and our predictors may predict a single peptide inducing
more than one class of antibodies. Thus, it does not
matter if a peptide has equal score for two models, and
it may be predicted in two classes if the SVM score is
more than the threshold. In our revised manuscript, we
have clarified this point.
Reviewer comments: Since the matrics for their
method (MCC) are apparently worse than published
methods for (antibody-neutral) epitope prediction, the
authors should evaluate a two-stage classification process
whereby an antibody-neutral classification is performed,
and then the positive results are passed to their method.
This would simplify the learning task because their
method would not have to learn to distinguish non-BCEs
from BCEs.
Authors’ response: The aim of this study is to predict
antibody specific BCEs instead of BCEs. For the first time,
we have developed models for predicting antibody class
specific-BCEs that may induce three types of anti-
bodies (IgA, IgE and IgG). Thus, it is not possible to
compare this method with the previous methods as
earlier methods have been developed for predicting
BCEs only.
Reviewer comments: The manuscript also has some
flaws that need to be addressed. Primarily, they should
cite and discuss other SVM-based methods for epitope
prediction. Additionally, it is not clear whether the
authors understand that SMO is, in fact, an algorithm
for learning SVMs. It seems strange to simply list SMO
among the non-SVM algorithms.
Typos: There are a number of typos that can be identi-
fied by using a spell-checker. The authors meant to say
that there are five primary isotypes at the end of the first
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correctly list the five classes).
Authors’ response: As suggested by reviewer, we have
cited other SVM-based methods published earlier for
epitope prediction. We have also edited the manuscript
as per reviewer’s suggestion. Since there are different
versions of Support Vector Machines (like SVMlight and
SMO), we tried one from SVMlight and other from
WEKA package (SMO). As the reviewer has advised, we
have placed SMO in SVM algorithms from non-SVM
algorithms.
Reviewer comments: Quality of written English:
Needs some language corrections before being published
Authors’ Response: We have tried our best to im-




Reviewer comments: Quality of written English:
Needs some language corrections before being publishedReferee 3: Dr Lina Ma (nominated by Dr Zhang Zhang)
This manuscript presented a method to predict B-cell
epitopes that can induce a specific class of antibody and
attempted to understand the relation between primary
sequence of epitopes and the class of antibodies. My
comments are listed as follows.
Reviewer comments: It is noticed that one paper pub-
lished by the authors, entitled “Improved Method for
Linear B-Cell Epitope Prediction Using Antigen’s Pri-
mary Sequence”, describes the method of B-cell epitope
prediction”. Is the method presented here similar with
that in the published one? As the authors used non-
BCEs as a negative control in both papers, I wonder
what is the correlation between this manuscript and the
published one and it might be better to describe it
clearly or discuss any issue caused.
Authors’ response: As indicated by reviewer, recently
our group has published a paper [35] describing a
method developed for predicting linear B-cell epitopes
(in revised version of this paper, we have cited and
discussed our recent paper). In the past, other methods
have also been developed for predicting B-cell epitopes
(including our recent paper [35]). In the present paper,
for the first time, we have developed a method for
predicting epitopes that can induce specific class of anti-
bodies. In the revised manuscript, we have clarified the
difference between IgPred and previous methods.
Reviewer comments: It is highly recommended that
the manuscript describe their results in a more clarified
and detailed manner.a) In Figure 1, it is obvious that Pro and Gln are
abundant in IgA inducing epitopes, but I do not
think that Cys and Glu are dominated in IgE
inducing epitopes. In Figure 2, IgA inducing epitopes
contain more LP, LQ, PF, PQ, PY, QP, QL and QQ
dipeptides while the IgG inducing epitopes and IgE
epitopes do not tend to show a significant difference
in any dipeptide compositions among the three
kinds of epitopes.
b) Some statistical methods should be used to compare
the difference between epitopes, and it is better to
list results with significant differences.
c) Error bars should be added in the histogram of
Figures to show deviations.
Authors’ response: We agree with the reviewer in the
points (a, b and c) and after getting valuable comments
from the reviewer, we performed Welch’s t-test for each
class of epitopes (IgG, IgE, IgA, and non-BCE). As an
example, we first calculated average of dipeptide compo-
sitions (400 dipeptides) for both IgG(+) data and IgG(−)
data. Further with the help of t-test, we calculated the
difference of means of both the datasets for each of 400
dipeptides. Looking at the large number of dipeptides
(400), we removed Figure 2 (showing dipeptide compos-
ition as bar graph) and provided the dipeptide compos-
ition of all the three classes with their negatives along
with p-value in separate Additional file 1. With such
analysis, it can be observed (in the Supplementary excel
sheet) that significant dipeptides such as AS, GP, WK,
YR, etc. are found to be dominant in IgG-inducing epi-
topes; IQ LA, NA, NE, etc. are frequent in IgE-inducing
epitopes; and ED, FP, PF, PQ, PY, QP, etc. are prevailing
in IgA-inducing epitopes. We have also discussed these
observations in the revised manuscript.
As per reviewer’s suggestion, we performed Welch-s t-
test on dipeptide composition data to look at the signifi-
cant difference between positive and negative data of
each class.
We have also added error bars to the amino acid com-
position bar graph as per reviewer’s recommendation.
d) In Figure 1, non-BCEs were used as a negative
control. It is better that negative control is also
used in Figure 2. Similar problems also exist in
sections of “Residue preference”, “Length of
epitopes”, “Physico-chemical property analysis”,
“Motifs analysis”. It is better that negative control
(non-BCEs) should be used consistently with Figure 1.
Authors’ response: As suggested by the reviewer, we
have added AAC of non-BCE in Figure 1. We replaced
Figure 2 with excel sheet showing DPC of 400 dipeptides
(Additional file 1).
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tables, what about sensitivity and specificity
Authors’ response: Since there were about six fea-
tures for each of the three classes of epitopes, we did
not include sensitivity and specificity in the result tables.
After getting suggestion of the reviewer, we created add-
itional tables (Table S2 and S4) containing sensitivity
and specificity and incorporated as supplementary infor-
mation (Additional file 3: Table S2 and Additional file 3:
Table S4).
f ) What does AAP mean? What is the difference
between AAP and DPC?
Authors’ response: AAP (Amino acid propensity) is a
feature, which is derived from DPC of the datasets. This
feature has been exploited in previous B-cell epitope
prediction algorithms [33,40,41,43]. This represents the
DPC of a protein/amino acid sequence weighted by the
amino acid propensity of each dipeptide in a matrix
made by both positive and negative data. We have edited
the manuscript by describing it in detail.
Reviewer comments: Discussion Section- At the
end of the first paragraph, it is concluded that SVM
performed better than WEKA. This is an important
conclusion of this paper, which should be explained
in detail.
Authors’ response: As we can observe in the sup-
plementary tables S8 and S9, algorithms of WEKA
(IBk, Random Forest and SMO) could perform rea-
sonably well with DPC as input feature. At the same
time, using SVMlight with DPC as input feature, the
performances of different models were significantly
better than those of WEKA as a whole. As suggested
by the reviewer, we have discussed the performances
of SVM and WEKA modules in detail in the discus-
sion section.
Reviewer comments: At the end of paragraph 2,
please explain “reasonable accuracy” in detail?
Authors’ response: As suggested by the reviewer, we
have explained the accuracies of our models on inde-
pendent dataset in detail. For BalanceVar data, model
(ten-fold cross validation) developed on training data
achieved maximum MCC of 0.42, 0.61 and 0.39 while
MCC of 0.37, 0.63 and 0.49 were achieved on evalu-
ation datasets of IgG, IgE and IgA classes respectively.
Similarly, for BalanceFix data, model performed well
and achieved maximum MCC of 0.42, 0.70 and 0.46
on training data while MCC of 0.43, 0.62 and 0.33
were achieved on evaluation datasets of IgG, IgE and
IgA classes respectively. We have also discussed this
issue in the revised manuscript as per reviewer’s
suggestion.Reviewer comments: IgA inducing epitopes are
quite different from IgE or IgG inducing epitopes in
AAC and AAP comparison. However, SVM models
for predicting IgA inducing epitopes do not seem to
perform better than that for predicting IgE and IgG
inducing epitopes. This is really confusing for me, or
it might be better to provide explanations for this
result.
Authors’ response: We agree with the reviewer that
IgA epitopes are quite different. We examined the per-
formance of prediction of IgA inducing epitopes, as well
as the reason for the poor performance of these models. It
could be due to the fact that IgA inducing epitopes are
very limited in comparison to non-IgA inducing epi-
topes. It is a well-known fact that machine learning
techniques, particularly SVM-based models perform
poor especially when positive and negative dataset is
unbalanced. We have mentioned these points in the
revised manuscript.
Reviewer comments: As there have been methods for
predicting IgE inducing epitopes, what is the difference
between previous methods and the models described in
the manuscript?
Authors’ response: We agree with the reviewer that
there are methods developed for prediction of IgE
inducing epitopes (one is from our own group [17]). The
current study can be considered as an extension of the
previous studies. This study offers researcher to compare
the potential of an epitope to induce systemic type
(IgG), mucosal type (IgA) and inflammatory type (IgE)
of antibody immune response. Thus in contrast to the
predictors of IgE inducing epitopes, our web server is
more comprehensive with reference to antibody im-
mune response.
Reviewers’ comments on the revised manuscript
Referee 3: Dr Lina Ma (nominated by Dr Zhang Zhang)
Reviewer comments: The authors have answered all the
questions seriously, while there are still some mistakes
in the revised version. It is better that the authors check
the manuscript carefully before submission.
Section “Composition analysis”, paragraph 1, line 6, the
word “Glu” should be Gln. Section “Discussion”, para-
graph 1, lines 19–20, this sentence seems incomplete.
The authors say that they have mentioned these points
in the revised manuscript in answering my third ques-
tion of Section “Discussion”, while I did not find where
they have mentioned.
Authors’ response: We are thankful to the reviewer
for appreciating our efforts. As suggested by the re-
viewer, we have edited the manuscript and incorporated
all the suggestions. The performance of WEKA has been
discussed in result and discussion section after getting
the comments of reviewer.
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